InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Ingalls Kerry D.. Officer active across 1 company, notably Poseida Therapeutics, Inc.. Cumulatively, 3 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €23k. Activity tracked since 17 November 2021. The latest transaction was filed on 16 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
3,000 shares@ US$3.9830.6% of flowCommon StockSEC:0001209191-22-020153:0
Canonical exit: 14 Jun 2022 (T+90)
50,000 shares0Common StockSEC:0001209191-22-014377:0
2,000 shares@ US$7.0034.7% of flowCommon StockSEC:0001209191-21-065673:0
Canonical exit: 15 Feb 2022 (T+90)
3 of 3 declarations
About Ingalls Kerry D.
Ingalls Kerry D. is a declarant linked to Poseida Therapeutics, Inc., where the listed role is Chief Operating Officer. The record shows 4 filings in total, and among the recent filings tracked, acquisitions totaling EUR 35,617 between 2021-11-18 and 2022-03-18, with EUR 0 in sales.
